Axovant Gene Therapies
Why Robinhood?
You can watch AXGT and buy or sell other stocks, ETFs, and their options commission-free!About AXGT
Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY.
AXGT Key Statistics
Stock Snapshot
As of today, Axovant Gene Therapies(AXGT) shares are valued at $0.40. The company's market cap stands at 35.36M, with a P/E ratio of -1.22.
On 2026-03-12, Axovant Gene Therapies(AXGT) stock opened at —, reached a high of —, and a low of —.
The Axovant Gene Therapies(AXGT)'s current trading volume is 0, compared to an average daily volume of 218.56K.
During the past year, Axovant Gene Therapies(AXGT) stock moved between $0.25 at its lowest and $0.50 at its peak.
During the past year, Axovant Gene Therapies(AXGT) stock moved between $0.25 at its lowest and $0.50 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.